全文获取类型
收费全文 | 176090篇 |
免费 | 14683篇 |
国内免费 | 6822篇 |
专业分类
耳鼻咽喉 | 1784篇 |
儿科学 | 2956篇 |
妇产科学 | 3895篇 |
基础医学 | 19989篇 |
口腔科学 | 3675篇 |
临床医学 | 20649篇 |
内科学 | 30104篇 |
皮肤病学 | 2661篇 |
神经病学 | 10908篇 |
特种医学 | 6140篇 |
外国民族医学 | 41篇 |
外科学 | 21892篇 |
综合类 | 19786篇 |
现状与发展 | 20篇 |
一般理论 | 94篇 |
预防医学 | 12087篇 |
眼科学 | 4374篇 |
药学 | 16229篇 |
115篇 | |
中国医学 | 6613篇 |
肿瘤学 | 13583篇 |
出版年
2024年 | 391篇 |
2023年 | 2173篇 |
2022年 | 4923篇 |
2021年 | 7128篇 |
2020年 | 5053篇 |
2019年 | 4995篇 |
2018年 | 5443篇 |
2017年 | 4719篇 |
2016年 | 4489篇 |
2015年 | 6598篇 |
2014年 | 8572篇 |
2013年 | 9112篇 |
2012年 | 13636篇 |
2011年 | 14334篇 |
2010年 | 9417篇 |
2009年 | 7862篇 |
2008年 | 10490篇 |
2007年 | 10499篇 |
2006年 | 9886篇 |
2005年 | 9078篇 |
2004年 | 7049篇 |
2003年 | 6424篇 |
2002年 | 5503篇 |
2001年 | 3614篇 |
2000年 | 3355篇 |
1999年 | 3177篇 |
1998年 | 1741篇 |
1997年 | 1558篇 |
1996年 | 1239篇 |
1995年 | 1195篇 |
1994年 | 1092篇 |
1993年 | 716篇 |
1992年 | 1254篇 |
1991年 | 1138篇 |
1990年 | 975篇 |
1989年 | 839篇 |
1988年 | 783篇 |
1987年 | 692篇 |
1986年 | 590篇 |
1985年 | 545篇 |
1984年 | 399篇 |
1983年 | 371篇 |
1982年 | 263篇 |
1981年 | 251篇 |
1980年 | 235篇 |
1979年 | 322篇 |
1978年 | 261篇 |
1977年 | 218篇 |
1974年 | 236篇 |
1972年 | 207篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
62.
Selecting an appropriate working correlation structure is pertinent to clustered data analysis using generalized estimating equations (GEE) because an inappropriate choice will lead to inefficient parameter estimation. We investigate the well‐known criterion of QIC for selecting a working correlation structure, and have found that performance of the QIC is deteriorated by a term that is theoretically independent of the correlation structures but has to be estimated with an error. This leads us to propose a correlation information criterion (CIC) that substantially improves the QIC performance. Extensive simulation studies indicate that the CIC has remarkable improvement in selecting the correct correlation structures. We also illustrate our findings using a data set from the Madras Longitudinal Schizophrenia Study. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
63.
64.
65.
Sandra Urdaneta Hartmann Brian Wigdahl Elizabeth B Neely Cheston M Berlin Cara-Lynne Schengrund Hung-Mo Lin Mary K Howett 《Journal of human lactation》2006,22(1):61-74
Reduction of transmission of human immunodeficiency virus type 1 (HIV-1) through human milk is needed. Alkyl sulfates such as sodium dodecyl sulfate (SDS) are microbicidal against HIV-1 at low concentrations, have little to no toxicity, and are inexpensive. The authors have reported that treatment of HIV-1-infected human milk with < or = 1% (10 mg/mL) SDS for 10 minutes inactivates cell-free and cell-associated virus. The SDS can be removed with a commercially available resin after treatment without recovery of viral infectivity. In this article, the authors report results of selective biochemical analyses (ie, protein, immunoglobulins, lipids, cells, and electrolytes) of human milk subjected to SDS treatment and removal. The SDS treatment or removal had no significant effects on the milk components studied. Therefore, the use of alkyl sulfate microbicides to treat milk from HIV-1-positive women may be a simple, practical, and nutritionally sound way to prevent or reduce transmission of HIV-1 while still feeding with mother's own milk. 相似文献
66.
67.
68.
69.
70.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献